Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

Paolo Prandoni,Anthonie W.A. Lensing,Martin H. Prins,Martin Gebel,Akos F. Pap,Martin Homering,Rupert Bauersachs,Jan Beyer-Westendorf,Henri Bounameaux,Alexander T. Cohen,Bruce L. Davidson,Bonno van Bellen,Peter Verhamme,Philip S. Wells,Zhong Yuan,Bennett Levitan,Jeffrey I. Weitz

Thrombosis Research（2018）

引用 0|浏览0

暂无评分

摘要

•Many patients with venous thromboembolism require extended therapy•Full- or lower-dose anticoagulation therapy or aspirin can be used•Compared with aspirin, once-daily rivaroxaban (20 mg or 10 mg) reduces recurrent venous thromboembolism with a favorable benefit-risk profile

查看译文

关键词

venous thromboembolism,rivaroxaban,aspirin,extended treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要